Evaluation of Neutrophil-Lymphocyte Ratio as Inflammatory Marker in Chronic Kidney Disease Stage 3 and 4. Mugda Med. Coll. J. 2024;7(1):4-8. doi:10.3329/mumcj.v7i1.73955